期刊文献+

2型糖尿病伴血脂异常的研究进展 被引量:19

Type 2 Diabetes with Dyslipidemia Research
下载PDF
导出
摘要 2型糖尿病患者常存在高脂血症,大约有50%合并血脂异常,2型糖尿病患者心血管疾病发生率和病死率也较高,高脂血症可以先于高血糖出现,但更多则是伴随糖代谢紊乱而作为糖尿病或代谢综合征的一部分。本文回顾了糖尿病伴血脂异常的可能机制及药物干预方法,多项研究均证明对糖尿病患者进行积极调脂治疗能显著减少其冠状动脉粥样硬化性心脏病的发生率和病死率。 Patients with type 2 diabetes often exists Hyperlipemia,about 50% of patients complicated with dyslipidemia,the incidence and mortality of the cardiovascular disease in these patients is also high. Hyperlipidemia can appear in high blood sugar, but sugar is a metabolic disorder associated with diabetes or as part of the metabolic syndrome. This article reviewed the possible mechanisms and drug treatments of the dyslipidemia in diabetes,and found that the active interference in blood lipid disorder can significantly reduce the incidence and mortality of the coronary heart disease in diabetes mellitus.
出处 《医学综述》 2009年第23期3626-3629,共4页 Medical Recapitulate
关键词 2型糖尿病 血脂异常 机制 药物治疗 Type 2 diabetes mellitus Dyslipidemia Mechanism Drug therapy
  • 相关文献

参考文献24

  • 1Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol of Education Program (NCEP)Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults( Adult Treatment Panel Ⅲ ) [ J ]. JAMA, 2001,285 ( 9 ) : 2486-2497.
  • 2Eckel RH. Lipoprotein lipase:a multifunctional enzyme relevant to common metabolic diseases [ J ]. N Engl J Med, 1989,320 ( 16 ) : 1060-1081.
  • 3Lagrest L,Gambert P, Jallent C. Combinedh effects of lipid transfers and lipulsis on gradieal gel patterns of human plasma LDL [ J ]. Arteriose Thromb, 1994,14 ( 8 ) : 1327-1336.
  • 4黄瑞英,姜宝法.2型糖尿病血脂代谢异常的临床进展[J].中国老年学杂志,2008,28(2):202-205. 被引量:29
  • 5时强,荣烨之,张懋贞,陈捷.辛伐他汀对动脉粥样硬化斑块内巨噬细胞MMP-3表达的影响[J].中国医药导刊,2005,7(1):46-48. 被引量:8
  • 6Nakanishi N, Nakamura K, Suzuki K, et al. Relation of body weijht chanje to changes in atherogenic traits : a study of middle-aged Japanese obese male office workers [ J ]. Ind Health, 2000,38 ( 2 ) : 233 -238.
  • 7Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease : the Scandinavian Simvastatin Survival Study ( 4S ) [ J ]. Lancet, 1994,344 ( 8934 ) : 1383-1389.
  • 8Goldberg RB, Mellies M J, Sacks FM, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events( CARE ) trial. The Care Investigators [ J ]. The Care Investigators Circulation,1998,98(23) :2513-2519.
  • 9The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J]. N Engl J Med, 1998, 339(19) :1349-1357.
  • 10Shepherd J,Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group [ J ]. N Engl J Med, 1995,333 (20) : 1301-1307.

二级参考文献37

共引文献291

同被引文献230

引证文献19

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部